Revolutionizing Patient Access and Support for Multiple Sclerosis

Abstract: Multiple sclerosis (MS) is a chronic disease often causing progressive debilitation for nearly one million Americans. Novel therapies exist that can help slow disease progression and limit new symptoms. Without assistance from support services, MS patients face significant challenges in accessing, affording and adhering to these complex, specialty medications. This report describes major barriers keeping MS patients from needed therapies along with inefficiencies of the traditional model for patient access and support services that suppress enrollment and delay time to therapy. A new technological innovation from CoverMyMeds that solves for these specialty access and support problems is introduced.

Fill out the form below to access the white paper.

* Required
There was an error submitting the form. Please try refreshing the page or check back later.